Differentiated Therapeutics Inc
What if you could predict molecules to make the cause of disease disappear?
3 employees · est. 2021 · San Diego, United States
Plexium
Pushing the Boundaries of Targeted Protein Degradation to Improve Lives
35 employees · est. 2018 · San Diego, United States
Plexium is the older company (2021 vs 2018); Plexium is the larger of the two.
Side-by-Side Comparison
| Metric | Differentiated Therapeutics Inc | Plexium |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | San Diego, United States | San Diego, United States |
| Employees | ||
| Employees | 3 | 35 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | $5.00M | $165.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 6 |
| Services | ||
| Services | End-to-End Discovery Engine for Protein Degradation, Automatic Differentiation Platform, Degrader Therapeutics Design, Portfolio Planning and Screening with DTKG | Rational design and discovery of protein degraders, Development of targeted protein degradation therapeutics, Clinical trials |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotech Researchers, Healthcare Providers, Patients with Unmet Medical Needs | Patients with high unmet medical needs, Healthcare institutions and systems, Pharmaceutical partners |
| Taxonomy | ||
| Taxonomy | Targeted Protein Degradation, Protein Degraders, Drug Discovery, Disease Modification, Genetic Drivers, Therapeutic Development, Novel Therapies, Unmet Medical Needs, Molecular Prediction, Optimization Engine, Innovative Healthcare, Precision Medicine, Pharmaceutical R&D, Disease Elimination | Targeted Protein Degradation, Next-Generation Therapeutics, Monovalent Direct Degraders, Molecular Glues, Small Molecule Drugs, High Unmet Medical Needs, DELTA Discovery Platform, Ultra-High Throughput Screening, Cancer Therapies, Clinical-Stage Degraders, Druggable Target Expansion, Protein Degraders, PROTAC Alternatives, Therapeutic Innovation |
| Website | ||
| Website | dxtherapeutics.com | plexium.com |
About Differentiated Therapeutics Inc
Differentiated Therapeutics Inc is an emerging player in the Biotechnology landscape, founded in 2021 and headquartered in the United States. With a compelling slogan—“What if you could predict molecules to make the cause of disease disappear?”—the company has positioned itself at the forefront of i...
About Plexium
Plexium, founded in 2018, is a pioneering biotechnology company based in the United States. The company is redefining the landscape of targeted protein degradation (TPD) with the ambitious mission of "Pushing the Boundaries of Targeted Protein Degradation to Improve Lives." Plexium's innovation pr...
We will tell you when either one moves
BounceWatch watches Differentiated Therapeutics Inc and Plexium for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Differentiated Therape... and Plexium — by email.
Frequently Asked Questions
Compare Differentiated Therapeutics Inc with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Differentiated Therapeutics Inc on 11 Mar 2026, and Plexium on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.